This topic contains a solution. Click here to go to the answer

Author Question: In an effort to prevent re-hospitalization through provision of comprehensive, integrated community ... (Read 53 times)

drink

  • Hero Member
  • *****
  • Posts: 554
In an effort to prevent re-hospitalization through provision of comprehensive, integrated community services, the program that assigns a schizophrenic client to a specific multidisciplinary team is:
 
  A) Aromatherapy.
  B) Group therapy.
  C) ECT.
  D) ACT.

Question 2

The nurse and a client talk about the signs and symptoms of acute mania. The client states, When I am feeling really good and don't need to sleep, I am manic, but the last thing I want is treatment..
 
  The nurse recognizes that this experience is indicative of the need for: A) Right to treatment. B) Informed consent.
  C) Competency. D) Advance directive for psychiatric care.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xthemafja

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

D

Answer to Question 2

D




drink

  • Member
  • Posts: 554
Reply 2 on: Jul 19, 2018
Wow, this really help


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library